David Dongliang Ge
Apostle Inc, USA
Biography
David Dongliang Ge is the CEO and President of Apostle Inc., a Silicon-Valley-based Biotechnology Company developing a novel AI-enabled Nano Diagnostics (AID) Technology for early cancer detection. Previously, he was the President of BioSciKin Co. and Simcere Diagnostics Co., two global biotechnology companies headquartered in Nanjing, China. Between 2011 and 2016, he was the Director of Bioinformatics at Gilead Sciences, where he founded and provided Leadership to the Bioinformatics group.
Abstract
Abstract : Genomic approaches in modern biotechnology - From discovery translation to implementation